Other Dehydrogenase Inhibitors
| Cat. No. | Product Name / Activity |
|---|---|
| 8039 | BI 3231 New |
| Potent and selective hydroxysteroid 17β dehydrogenase 13 (HSD17B13) inhibitor | |
| 5348 | 6,8-Bis(benzylthio)octanoic acid |
| PDH and KGDH inhibitor | |
| 5492 | BMS 566419 |
| Inosine monophosphatase dehydrogenase (IMPDH) inhibitor | |
| 2966 | CGP 3466B maleate |
| GAPDH inhibitor; neuroprotective | |
| 7561 | G6PDi 1 |
| Potent, reversible glucose-6-phosphate dehydrogenase (G6PD) inhibitor | |
| 6322 | LW 6 |
| Malate dehydrogenase-2 (MDH2) inhibitor; also inhibits HIF-1α | |
| 4979 | Methylmalonate |
| Succinate dehydrogenase inhibitor | |
| 4102 | Mycophenolate mofetil |
| Inosine monophosphate dehydrogenase (IMPDH) inhibitor | |
| 1505 | Mycophenolic acid |
| Inosine monophosphatase dehydrogenase (IMPDH) inhibitor | |
| 4501 | Ribavirin |
| IMPDH inhibitor; antiviral guanosine analog | |
| 5759 | SW 033291 |
| High affinity 15-PGDH inhibitor; promotes hematopoiesis and hepatocyte proliferation | |
| 7719 | TH 9619 disodium salt |
| MTHFD2 inhibitor |
Cancer Metabolism Product Guide
Our product guide reviews some of the main areas in cancer metabolism research and highlights products that can be used to explore metabolic pathways.
Request copyRequest PDFCancer Metabolism Life Science Poster
Taken from the Cancer Product Guide Edition 3
Our Cancer Metabolism poster summarizes the main metabolic pathways in cancer cells, and highlights potential targets for cancer therapeutics.
Request copyDownload PDF